-
Capital Commentary: 05-16-2026
This week, The Numbers’ diversified equity portfolio navigated a volatile market with mixed results, ultimately ending with a slight dip of 0.10%. Interestingly, our performance trailed the S&P 500 by just a fraction, with the index showing a slightly lesser loss of -0.02%. Despite this minor setback, an impressive 78% of our trades were successful,…
-
Capital Commentary: 05-09-2026
In an eventful week of trading, The Numbers portfolio saw a mix of celebrations and setbacks across its holdings, managing a modest overall appreciation of 0.68%—lagging slightly behind the S&P 500’s robust climb of 2.73%. Here’s a closer look at how individual equities fared and what might have been driving their performance. Leading the charge…
-
Capital Commentary: 05-02-2026
In an eventful week of trading, The Numbers maneuvered decisively across various markets, capitalizing on opportunities in equities that reverberate with broader economic trends. When examining portfolio performance, our equity strategy yielded a modest overall gain of 0.59%. However, this was slightly below the S&P 500 benchmark, which rose by 0.77% over the same period…
-
Capital Commentary: 04-25-2026
In a brisk week of trading, The Numbers’ portfolio navigated the choppy waters of the financial markets with mixed results. A notable star performer was UnitedHealth Group. Going long on this titan of the health insurance industry paid off handsomely, yielding an impressive 13.98% return. Investors were buoyed by reassuring earnings reports and robust growth…
-
Capital Commentary: 04-18-2026
In a dynamic week of trading, The Numbers maneuvered through an unpredictable market with a mix of bullish and bearish strategies across ten equities. The portfolio managed to eke out a total gain of 1.39%, albeit underperforming the S&P 500’s robust 3.50% rally. One of the week’s star performers was the Russell 2000 iShares ETF,…
